Sigyn Therapeutics, Inc.

SIGY

Financials

10-QQ3 ended 09/30/2511/14/2510-QQ2 ended 06/30/2509/05/2510-QQ1 ended 03/31/2505/20/2510-KFY 202404/15/2510-QQ3 ended 09/30/2411/19/24

Disclosures

8-KEntry into Material Agreement; Unregistered Sales of Equity02/20/268-KEntry into Material Agreement; Unregistered Sales of Equity; Change in Directors or Officers; Other Events08/15/258-KChange in Directors or Officers; Regulation FD Disclosure03/07/258-KChange in Directors or Officers01/16/258-KAmendments to Articles or Bylaws01/06/25

Prospectuses and Registrations

S-1/ARegistration statement (amended)04/10/24S-1/ARegistration statement (amended)09/22/23S-1/ARegistration statement (amended)05/10/23S-1/ARegistration statement (amended)02/28/23S-1/ARegistration statement (amended)12/23/22

Proxies

DEF 14CDefinitive information statement09/21/20PRE 14CPRE 14C09/09/20DEF 14CDefinitive information statement03/10/20PRE 14CPRE 14C02/25/20DEF 14CDefinitive information statement10/02/19

Ownership

SC 13G/ABeneficial ownership (amended)01/14/26SC 13G/ABeneficial ownership (amended)02/14/25SC 13G/ABeneficial ownership (amended)02/08/24SC 13G/ABeneficial ownership (amended)02/04/22SC 13G/ABeneficial ownership (amended)01/27/21

Other

15-12GCertification of termination of registration07/16/26NT 10-KLate filing notification (10-K)03/31/26NT 10-QLate filing notification (10-Q)08/15/25NT 10-QLate filing notification (10-Q)05/15/25NT 10-KLate filing notification (10-K)03/31/25